quizartinib
daiichi sankyo
['myeloid', 'quizartinib']
oncology news update: 'eha 2022: quizartinib improves overall survival in adults with flt3-itd+ acute myeloid leukaemia' has been published on oncology news australia - #oncnews 
Creating Innovative Resources for the Australian Oncology Community and Beyond. Home of The Oncology Newsletter, The Oncology Podcast and https://t.co/xBVIOdvL7D